Parkinson Disease Agent KM-819 Demonstrates Safe Profile in Phase 2 Study Neurology Live, 24 Jan 2023 KM-819, a potent inhibitor of FAF1, a key regulatory protein in cell death pathways, is currently being assessed in a 2-part…